Sign Up to like & get
recommendations!
1
Published in 2017 at "OncoImmunology"
DOI: 10.1080/2162402x.2017.1315495
Abstract: ABSTRACT Expression of human epidermal growth factor family member 3 (HER3), a critical heterodimerization partner with EGFR and HER2, promotes more aggressive biology in breast and other epithelial malignancies. As such, inhibiting HER3 could have…
read more here.
Keywords:
immune checkpoint;
responses immune;
checkpoint inhibition;
her3 ... See more keywords